Spotlight on Zuellig Pharma in Asia Pacific Healthcare

On Biztech Asia’s C Suite Conversations show, we discuss the Clinical Reach business, with Giuseppe Leo, Senior Vice President for Clinical Reach at Zuellig Pharma, a healthcare solutions provider committed to improving accessibility to healthcare.

Key takeaways:

Clinical Reach as a business: Clinical Reach is a relatively new business, assisting labs and biotechs in local markets in completing and validating clinical trials. Infrastructure and solutions that allow both incumbent players and smaller biotechs in emerging markets to continue their work are becoming more and more lucrative.
Zuellig Pharma’s market presence strategy: Zuellig Pharma’s presence in other healthcare space verticals means that nurtured relationships with clients from the Clinical Reach division can also be translated into business relations in distribution, licensing, or other important factors in bringing new products to market.
Regional trends and APAC growth in the clinical business: APAC is growing as a space for clinical trials, leading to many large incumbent pharma/healthcare companies from either America or Europe expanding into Asia; Zuellig Pharma is an Asian-based company with global reach.